⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23101935 | 0.71 | — | — | |
| SCHEMBL19784289 | 0.71 | — | — | |
| SCHEMBL19184608 | 0.66 | KDM4E (0.33) | — | |
| SCHEMBL23153724 | 0.65 | — | — | |
| SCHEMBL20290976 | 0.65 | — | — | |
| Ethylene SCHEMBL4954344 | 0.65 | — | — | |
| SCHEMBL18791334 | 0.65 | — | — | |
| Ethylene SCHEMBL4954338 | 0.65 | — | — | |
| SCHEMBL8556951 | 0.63 | — | — | |
| SCHEMBL15868237 | 0.60 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024054955-A1 | HETEROBIFUNCTIONAL COMPOUNDS AND METHODS OF TREATING DISEASE | HALDA THERAPEUTICS OPCO, INC. (US) | 2024-03-14 | — | — | WO | disclosed |
| EP-3608329-A1 | MONOSUBSTITUTED DIAZABENZIMIDAZOLE CARBENE METAL COMPLEXES FOR USE IN ORGANIC LIGHT EMITTING DIODES | UDC Ireland Limited (IE) | 2020-02-12 | — | — | EP | disclosed |
| EP-3016960-B1 | MONOSUBSTITUTED DIAZABENZIMIDAZOLE CARBENE METAL COMPLEXES FOR USE IN ORGANIC LIGHT EMITTING DIODES | UDC IRELAND LTD (IE) | 2017-04-26 | — | — | EP | disclosed |